Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PL✓SelectedUSD · PLGSK vs PL performance historyLatest closeAs of-1.23%11/11
Stock and ETF performance explorer

GSK vs PL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+68.3%
PL return
+46.3%
Excess return
+22.0%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioPLExcessAlpha
1D-1.2%+0.5%-1.7%-1.2%
7D-1.1%+13.4%-14.4%-1.2%
30D+7.8%-10.2%+18.0%+7.9%
3M+0.3%-39.5%+39.8%+0.7%
6M+3.4%-65.7%+69.2%+4.2%
YTD+5.9%-27.3%+33.2%+5.8%
1Y+8.2%+15.0%-6.8%+7.5%
3Y+65.3%+560.8%-495.6%+57.8%
5Y+43.3%+38.4%+4.9%+39.0%
All+68.3%+46.3%+22.0%+61.9%

Cumulative growth

Daily Returns

Daily percentage return beside PL.

Daily Out/Under-Performance

Portfolio return minus PL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded PL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling